Stocks
Halozyme (HALO) R&D/CAPEX US GAAP (year values) |
|||||||||
| 2020 | 2021 | 2022 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| R&D/CAPEX, % | 1 367% | 2 448% | 1 385% | 1 385% | 499.3% | 723.7% | |||
| Changes by years, y/y, % | -2 118pp | +1 081pp | -1 064pp | 0pp | -885pp | -31.1% | |||
Halozyme. R&D/CAPEX, %
Halozyme. R&D/CAPEX, changes, pp
Halozyme (HALO) R&D/CAPEX US GAAP (quarter values) |
||||||||
| 2023Q1 | 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | LTM ? | |||
| R&D/CAPEX, % | 158.0% | 1 215% | 588.3% | 821.9% | 539.1% | 723.7% | ||
| Changes by years, y/y, % | -2 261pp | -384pp | -1 069pp | -141pp | +381pp | |||
| Changes by quarters, q/q, % | -805pp | +1 057pp | -627pp | +234pp | -283pp | |||
